Discovery of a Fluorinated Enigmol Analog with Enhanced in Vivo Pharmacokinetic and Anti-Tumor Properties
DOI: 10.1021/acsmedchemlett.6b00113
David S. Menaldino,
Deborah G. Culver,
Dennis C. Liotta,
Eric J. Miller,
G. Prabhakar Reddy,
Jason J. Holt,
John A. Petros,
Manohar Saindane,
Mark T. Baillie,
Michael G. Natchus,
Randy B. Howard,
Richard F. Arrendale,
Sarah T. Pruett,
Taylor J. Evers
Keywords: Sphingolipids, Enigmol, fluorination, prostate cancer
Abstract:
Full-Text
